Elekta AB (publ) (EKTA-B) - Total Assets

Latest as of January 2026: Skr27.68 Billion SEK ≈ $2.98 Billion USD

Based on the latest financial reports, Elekta AB (publ) (EKTA-B) holds total assets worth Skr27.68 Billion SEK (≈ $2.98 Billion USD) as of January 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check EKTA-B cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Elekta AB (publ) - Total Assets Trend (2002–2025)

This chart illustrates how Elekta AB (publ)'s total assets have evolved over time, based on quarterly financial data. Explore Elekta AB (publ) (EKTA-B) investment intensity to see how much of total assets are deployed in long-term investments.

Elekta AB (publ) - Asset Composition Analysis

Current Asset Composition (April 2025)

Elekta AB (publ)'s total assets of Skr27.68 Billion consist of 46.3% current assets and 53.7% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr2.45 Billion 10.2%
Accounts Receivable Skr7.71 Billion 26.6%
Inventory Skr2.76 Billion 9.5%
Property, Plant & Equipment Skr1.91 Billion 6.6%
Intangible Assets Skr11.92 Billion 41.1%
Goodwill Skr6.89 Billion 23.8%

Asset Composition Trend (2002–2025)

This chart illustrates how Elekta AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Elekta AB (publ).

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Elekta AB (publ)'s current assets represent 46.3% of total assets in 2025, a decrease from 80.4% in 2002.
  • Cash Position: Cash and equivalents constituted 10.2% of total assets in 2025, down from 21.1% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 64.0% of total assets, an increase from 15.0% in 2002.
  • Asset Diversification: The largest asset category is intangible assets at 41.1% of total assets.

Elekta AB (publ) Competitors by Total Assets

Key competitors of Elekta AB (publ) based on total assets are shown below.

Company Country Total Assets
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
Germany €2.83 Billion
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
China CN¥16.89 Billion
Novocure Ltd
NASDAQ:NVCR
USA $787.93 Million
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
China CN¥2.00 Billion
Jafron Biomedical Co Ltd
SHE:300529
China CN¥5.52 Billion
Anteris Technologies Global Corp
AU:AVR
Australia AU$19.07 Million
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
China CN¥3.54 Billion
Tellgen Corp
SHE:300642
China CN¥2.01 Billion

Elekta AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.95 1.06 1.11
Quick Ratio 0.73 0.83 0.92
Cash Ratio 0.18 0.25 0.00
Working Capital Skr-723.00 Million Skr887.00 Million Skr1.31 Billion

Elekta AB (publ) - Advanced Valuation Insights

This section examines the relationship between Elekta AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.68
Latest Market Cap to Assets Ratio 0.07
Asset Growth Rate (YoY) -7.8%
Total Assets Skr28.98 Billion
Market Capitalization $2.04 Billion USD

Valuation Analysis

Below Book Valuation: The market values Elekta AB (publ)'s assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Elekta AB (publ)'s assets decreased by 7.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Elekta AB (publ) (2002–2025)

The table below shows the annual total assets of Elekta AB (publ) from 2002 to 2025.

Year Total Assets Change
2025-04-30 Skr28.98 Billion
≈ $3.12 Billion
-7.75%
2024-04-30 Skr31.41 Billion
≈ $3.38 Billion
+6.10%
2023-04-30 Skr29.61 Billion
≈ $3.19 Billion
+12.57%
2022-04-30 Skr26.30 Billion
≈ $2.83 Billion
+5.87%
2021-04-30 Skr24.84 Billion
≈ $2.67 Billion
-12.55%
2020-04-30 Skr28.41 Billion
≈ $3.06 Billion
+18.06%
2019-04-30 Skr24.06 Billion
≈ $2.59 Billion
+7.16%
2018-04-30 Skr22.46 Billion
≈ $2.42 Billion
+7.19%
2017-04-30 Skr20.95 Billion
≈ $2.25 Billion
+7.76%
2016-04-30 Skr19.44 Billion
≈ $2.09 Billion
-8.23%
2015-04-30 Skr21.18 Billion
≈ $2.28 Billion
+18.40%
2014-04-30 Skr17.89 Billion
≈ $1.93 Billion
+9.72%
2013-04-30 Skr16.31 Billion
≈ $1.75 Billion
+7.04%
2012-04-30 Skr15.23 Billion
≈ $1.64 Billion
+70.00%
2011-04-30 Skr8.96 Billion
≈ $964.45 Million
+5.25%
2010-04-30 Skr8.52 Billion
≈ $916.35 Million
+7.09%
2009-04-30 Skr7.95 Billion
≈ $855.65 Million
+25.77%
2008-04-30 Skr6.32 Billion
≈ $680.35 Million
+18.04%
2007-04-30 Skr5.36 Billion
≈ $576.39 Million
+1.36%
2006-04-30 Skr5.28 Billion
≈ $568.64 Million
+17.45%
2005-04-30 Skr4.50 Billion
≈ $484.16 Million
+46.26%
2004-04-30 Skr3.08 Billion
≈ $331.03 Million
+3.85%
2003-04-30 Skr2.96 Billion
≈ $318.76 Million
+16.80%
2002-04-30 Skr2.54 Billion
≈ $272.91 Million
--

About Elekta AB (publ)

ST:EKTA-B Sweden Medical Devices
Market Cap
$2.04 Billion
Skr18.94 Billion SEK
Market Cap Rank
#6265 Global
#87 in Sweden
Share Price
Skr51.60
Change (1 day)
-0.96%
52-Week Range
Skr40.64 - Skr63.25
All Time High
Skr125.13
About

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more